Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome

Abstract Women with germline PTEN variants (PTEN hamartoma tumor syndrome, PHTS) have up to 85% lifetime risk of female breast cancer (BC). We previously showed that PHTS-derived BCs are distinct from sporadic BCs both at the clinical and genomic levels. In this study, we examined somatic copy numbe...

Full description

Bibliographic Details
Main Authors: Takae Brewer, Lamis Yehia, Peter Bazeley, Charis Eng
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:npj Genomic Medicine
Online Access:https://doi.org/10.1038/s41525-023-00361-0
_version_ 1797784484092837888
author Takae Brewer
Lamis Yehia
Peter Bazeley
Charis Eng
author_facet Takae Brewer
Lamis Yehia
Peter Bazeley
Charis Eng
author_sort Takae Brewer
collection DOAJ
description Abstract Women with germline PTEN variants (PTEN hamartoma tumor syndrome, PHTS) have up to 85% lifetime risk of female breast cancer (BC). We previously showed that PHTS-derived BCs are distinct from sporadic BCs both at the clinical and genomic levels. In this study, we examined somatic copy number variations (CNV) and transcriptome data to further characterize the somatic landscape of PHTS-derived BCs. We analyzed exome sequencing data from 44 BCs from women with PHTS for CNV. The control group comprised of 558 women with sporadic BCs from The Cancer Genome Atlas (TCGA) dataset. Here, we found that PHTS-derived BCs have several distinct CNV peaks compared to TCGA. Furthermore, RNA sequencing data revealed that PHTS-derived BCs have a distinct immunologic cell type signature, which points toward cancer immune evasion. Transcriptomic data also revealed PHTS-derived BCs with pathogenic germline PTEN variants appear to have vitamin E degradation as a key pathway associated with tumorigenesis. In conclusion, our study revealed distinct CNV x transcript features in PHTS-derived BCs, which further facilitate understanding of BC biology arising in the setting of germline PTEN mutations.
first_indexed 2024-03-13T00:40:33Z
format Article
id doaj.art-5440b66ccc45435e80153901127bc4d1
institution Directory Open Access Journal
issn 2056-7944
language English
last_indexed 2024-03-13T00:40:33Z
publishDate 2023-07-01
publisher Nature Portfolio
record_format Article
series npj Genomic Medicine
spelling doaj.art-5440b66ccc45435e80153901127bc4d12023-07-09T11:20:09ZengNature Portfolionpj Genomic Medicine2056-79442023-07-018111010.1038/s41525-023-00361-0Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndromeTakae Brewer0Lamis Yehia1Peter Bazeley2Charis Eng3Genomic Medicine Institute, Lerner Research Institute, Cleveland ClinicGenomic Medicine Institute, Lerner Research Institute, Cleveland ClinicDepartment of Quantitative Health Sciences, Lerner Research Institute, Cleveland ClinicGenomic Medicine Institute, Lerner Research Institute, Cleveland ClinicAbstract Women with germline PTEN variants (PTEN hamartoma tumor syndrome, PHTS) have up to 85% lifetime risk of female breast cancer (BC). We previously showed that PHTS-derived BCs are distinct from sporadic BCs both at the clinical and genomic levels. In this study, we examined somatic copy number variations (CNV) and transcriptome data to further characterize the somatic landscape of PHTS-derived BCs. We analyzed exome sequencing data from 44 BCs from women with PHTS for CNV. The control group comprised of 558 women with sporadic BCs from The Cancer Genome Atlas (TCGA) dataset. Here, we found that PHTS-derived BCs have several distinct CNV peaks compared to TCGA. Furthermore, RNA sequencing data revealed that PHTS-derived BCs have a distinct immunologic cell type signature, which points toward cancer immune evasion. Transcriptomic data also revealed PHTS-derived BCs with pathogenic germline PTEN variants appear to have vitamin E degradation as a key pathway associated with tumorigenesis. In conclusion, our study revealed distinct CNV x transcript features in PHTS-derived BCs, which further facilitate understanding of BC biology arising in the setting of germline PTEN mutations.https://doi.org/10.1038/s41525-023-00361-0
spellingShingle Takae Brewer
Lamis Yehia
Peter Bazeley
Charis Eng
Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
npj Genomic Medicine
title Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
title_full Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
title_fullStr Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
title_full_unstemmed Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
title_short Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
title_sort integrating somatic cnv and gene expression in breast cancers from women with pten hamartoma tumor syndrome
url https://doi.org/10.1038/s41525-023-00361-0
work_keys_str_mv AT takaebrewer integratingsomaticcnvandgeneexpressioninbreastcancersfromwomenwithptenhamartomatumorsyndrome
AT lamisyehia integratingsomaticcnvandgeneexpressioninbreastcancersfromwomenwithptenhamartomatumorsyndrome
AT peterbazeley integratingsomaticcnvandgeneexpressioninbreastcancersfromwomenwithptenhamartomatumorsyndrome
AT chariseng integratingsomaticcnvandgeneexpressioninbreastcancersfromwomenwithptenhamartomatumorsyndrome